Relevant bibliographies by topics / Skin Diseases Treatment Thailand

Academic literature on the topic 'Skin Diseases Treatment Thailand'

Author: Grafiati
Published: 10 December 2022
Last updated: 29 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Skin Diseases Treatment Thailand.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Skin Diseases Treatment Thailand"

1

Saising, Jongkon, Katesarin Maneenoon, Oraphan Sakulkeo, Surasak Limsuwan, Friedrich Götz, and Supayang Piyawan Voravuthikunchai. "Ethnomedicinal Plants in Herbal Remedies Used for Treatment of Skin Diseases by Traditional Healers in Songkhla Province, Thailand." Plants 11, no. 7 (March 25, 2022): 880. http://dx.doi.org/10.3390/plants11070880.

Full text
Abstract:
Skin disorders are a worldwide health problem that normally affect human life. A traditional healer is an important expert in researching notable medicinal plants for skin disease treatment. This study aimed to determine the traditional knowledge and the use of medicinal plants for the treatment of skin diseases among traditional healers in the Songkhla province, Thailand. The ethnobotanical information was collected from experienced traditional healers by semi-structured interviews and participant observations. Plant specimens were also collected and identified using the standard taxonomic method. The data were analyzed by interpretation and descriptive statistics. Twenty-five polyherbal formulations for the treatment of skin diseases were obtained from traditional healers with at least 10 years of experience. A total of 66 plant species in 38 families were documented. Leaves and trees were the most commonly employed plant parts and plant habits included in the herbal remedies, respectively. Fabaceae, Rubiaceae, and Zingiberaceae were the majority of the cited families. Oryza sativa L. and Zingiber montanum (J. Koenig) Link ex A.Dietr. were the most preferred plants combined in the prescriptions, which had the highest use value (UV = 0.83). The highest relative frequency of citation was represented by Curcuma longa L., Eurycoma longifolia Jack, Knema globularia (Lamk.) Warb, and Senna siamea (Lam.) Irwin & Barneby. (0.55 each). This research suggests the importance of traditional healers in the healing of skin diseases with herbal remedies. A variety of medicinal plants are used in the prescriptions for the treatment of skin disorders in the Songkhla province, in the south of Thailand. Pharmacological and toxicological activities as well as phytochemical constituents of polyherbal remedies should be further investigated to scientifically verify further applications of widely practiced herbal medicines.
APA, Harvard, Vancouver, ISO, and other styles
2

Brimson, James Michael, Mani Iyer Prasanth, Dicson Sheeja Malar, Sirikalaya Brimson, and Tewin Tencomnao. "Rhinacanthus nasutus “Tea” Infusions and the Medicinal Benefits of the Constituent Phytochemicals." Nutrients 12, no. 12 (December 9, 2020): 3776. http://dx.doi.org/10.3390/nu12123776.

Full text
Abstract:
Rhinacanthus nasutus (L.) Kurz (Acanthaceae) (Rn) is an herbaceous shrub native to Thailand and much of South and Southeast Asia. It has several synonyms and local or common names. The root of Rn is used in Thai traditional medicine to treat snake bites, and the roots and/or leaves can be made into a balm and applied to the skin for the treatment of skin infections such as ringworm, or they may be brewed to form an infusion for the treatment of inflammatory disorders. Rn leaves are available to the public for purchase in the form of “tea bags” as a natural herbal remedy for a long list of disorders, including diabetes, skin diseases (antifungal, ringworm, eczema, scurf, herpes), gastritis, raised blood pressure, improved blood circulation, early-stage tuberculosis antitumor activity, and as an antipyretic. There have been many studies investigating the roles of Rn or compounds isolated from the herb regarding diseases such as Alzheimer’s and other neurodegenerative diseases, cancer, diabetes and infection with bacteria, fungi or viruses. There have, however, been no clinical trials to confirm the efficacy of Rn in the treatment of any of these disorders, and the safety of these teas over long periods of consumption has never been tested. This review assesses the recent research into the role of Rn and its constituent compounds in a range of diseases.
APA, Harvard, Vancouver, ISO, and other styles
3

Bronshteyn, Aleksandr M., L. V. Fedyanina, N. A. Malyshev, V. Ya Lashin, S. V. Burova, I. V. Davydova, M. S. Maksimova, and L. V. Sokolova. "ACUTE AND CHRONIC STRONGYLOIDIASIS IN RUSSIAN TOURISTS TRAVELLED TO THAILAND, THE COAST OF BLACK SEA IN RUSSIA AND ABKHAZIA: PROBLEMS OF DIAGNOSIS AND TREATMENT. ANALYSIS OF CASES AND REVIEW." Epidemiology and Infectious Diseases 22, no. 3 (June 15, 2017): 156–61. http://dx.doi.org/10.17816/eid40989.

Full text
Abstract:
Cases of acute and chronic Strongyloides stercoralis are presented as tourists travelled to Thailand, the coast of Black sea in Russia and Abkhazia. A high level of clinical suspicion is required to make the diagnosis of strongyloidiasis in at-risk patients presenting with peripheral eosinophilia, unexplained intermittent diarrhea, abdominal discomfort and skin rashes. Owing to increased risk of developing disseminated disease or hyperinfection syndrome, early detection and treatment of strongyloidiasis are extremely important. Strongyloidiasis should be routinely investigated in patients with chronic diseases who will undergo immunosuppressive therapy. Ivermectin or thiabendazole currently is the treatment of choice which are more effective than albendazole.
APA, Harvard, Vancouver, ISO, and other styles
4

Chanyachailert, Pattriya, Penvadee Pattanaprichakul, Sumanas Bunyaratavej, Charussri Leeyaphan, Bawonpak Pongkittilar, Chudapa Sereeaphinan, and David Stockman. "Evaluation of Clinical Knowledge Regarding Geriatric Skin Conditions among Thai Physicians." Siriraj Medical Journal 75, no. 1 (January 1, 2023): 1–6. http://dx.doi.org/10.33192/smj.v75i1.260522.

Full text
Abstract:
Objective: Assess the knowledge of common geriatric skin conditions in Thai physicians.Materials and Methods: This retrospective study was conducted among Thai physicians attending annual dermatology courses by the Dermatological Society of Thailand from 2016 to 2019. Data was assessed based on knowledge of diagnosis and management of common geriatric skin conditions.Results: A total of 197 participants, mainly general practitioners, were included. The highest percentage of correct diagnoses were benign erythematous, eczematous lesions (35.5%, senile purpura; 36.0%, xerotic eczema), and malignant diseases (35.5%, basal cell carcinoma; 27.4%, squamous cell carcinoma; 11.7%, subungual melanoma; 24.4%, acral lentiginous melanoma). In contrasts, the lowest percentage of correct diagnosis were premalignant diseases (0.5%, arsenical keratosis; 4.6%, actinic keratosis; 1.0% Bowen’s disease) and benign hypopigmented lesion (0.5%, stellate pseudoscar; 7.6%, idiopathic guttate hypomelanosis). Harmful treatment with systemic antifungal therapy was used in subungual melanoma (58.0%). Harmful management of senile comedone, subungual melanoma and acral lentiginous melanoma was significantly found in physicians given the incorrect diagnosis. (p = 0.027, p <0.001, p = 0.014, respectively).Conclusion: Most physicians recognized malignant lesions, benign erythematous or eczematous diseases in elderly skin. Surprisingly, almost all physicians couldn’t diagnose premalignant lesions and benign hypopigmented lesions.
APA, Harvard, Vancouver, ISO, and other styles
5

Velmani S, Perumal B, Santhosh C, and Maruthupandian A. "Phytochemical and Traditional uses on Acanthus ilicifolius (L)." JOURNAL OF ADVANCED APPLIED SCIENTIFIC RESEARCH 1, no. 3 (December 15, 2021): 43–48. http://dx.doi.org/10.46947/joaasr13201617.

Full text
Abstract:
Acanthus ilicifolius is a spiny herb found in mangrove of southern Thailand. It is also widely distributed in India and other tropical regions of Asia. The plant is reported to contain phytochemicals including alkaloid and wide range of glucosides (lignan and phenylethanoid). In traditional medicine, the plant is used in the treatment of diseases ranging from snake bite to skin diseases. A. ilicifolius (sea holly) occurs in tropical Asia and Africa, through Malaya to Polynesia. It is a vine shrub or tall herb, up to 1.5 m high, scarcely woody, bushy, with very dense growth. Common names of which are holy leaved acanthus, sea holly and holy mangrove. A. ilicifoliusis abundantly available in freshwater ecosystem of Pichavaram mangroves located in southeast coast of India. The review analyses traditional medicinal usage, and phytochemical investigations done on the A. ilicifoliusis medicinal plant.
APA, Harvard, Vancouver, ISO, and other styles
6

Assanangkornchai, Sawitri, Darika Saingam, Kanittha Thaikla, and Muhammadfahmee Talek. "Views and practices on medical cannabis of unlicensed providers in Thailand: a qualitative study." F1000Research 11 (March 29, 2022): 365. http://dx.doi.org/10.12688/f1000research.110367.1.

Full text
Abstract:
Background: Despite the legalization of cannabis use for medical purposes in Thailand in February 2019, illicit providers are still widespread and accessible. This study aimed to understand why people still chose to receive medical cannabis treatment or products from unlicensed or illegal providers. The practices of unlicensed or illegal providers in provision of medical cannabis products or treatment services were also examined. Methods: Qualitative in-depth interviews were conducted among medical cannabis providers and users, including 36 unlicensed and 7 licensed providers and 25 users in 2019-2021. Snowball sampling was used to recruit participants until saturation of data was achieved. Interviews included open-ended questions about the providers’ practices and attitudes towards medical cannabis. Interviews were recorded and transcribed, and thematic analysis was performed. Results: Overall, six reasons were identified to answer why unlicensed/illicit providers were still popular, including: 1) easy accessibility; 2) familiarity with the unlicensed providers before the legal scheme became available; 3) favorable characters (kind, supportive, non-judgmental) of unlicensed providers; 4) affordable treatment fees; 5) trust in the quality of the medicines; and 6) lack of knowledge and negative attitudes towards cannabis from healthcare professionals. Most providers started their career as medical cannabis providers by using it themselves or with their relatives and being satisfied with the results. They used cannabis products to treat all diseases, including skin, eyes, HIV/AIDS, non-communicable diseases and all kinds of cancers. Additionally, they believed that it was effective, with no or minimal adverse effects. Conclusions: This study suggests that some patients will continue receiving medical cannabis treatment and products from unlicensed or illegal providers. More attention should be paid on increasing the capacity of medical cannabis service systems within public health hospitals, and the certification of unlicensed providers, so as to integrate them into a regulated system.
APA, Harvard, Vancouver, ISO, and other styles
7

Sangboonruang, Sirikwan, Kuntida Kitidee, Panuwan Chantawannakul, Khajornsak Tragoolpua, and Yingmanee Tragoolpua. "Melittin from Apis florea Venom as a Promising Therapeutic Agent for Skin Cancer Treatment." Antibiotics 9, no. 8 (August 14, 2020): 517. http://dx.doi.org/10.3390/antibiotics9080517.

Full text
Abstract:
Melittin, a major component found in bee venom, is produced by the Apis species of the honey bee. In this study, the effect of melittin derived from Apis florea (Mel-AF), which is a wild honey bee species that is indigenous to Thailand, was investigated against human malignant melanoma (A375) cells. In this study, Mel-AF exhibited considerable potential in the anti-proliferative action of A375 cells. Subsequently, the cellular mechanism of Mel-AF that induced cell death was investigated in terms of apoptosis. As a result, gene and protein expression levels, which indicated the activation of cytochrome-c release and caspase-9 expression, eventually triggered the release of the caspase-3 executioner upon Mel-AF. We then determined that apoptosis-mediated cell death was carried out through the intrinsic mitochondrial pathway. Moreover, advanced abilities, including cell motility and invasion, were significantly suppressed. Mel-AF manipulated the actin arrangement via the trapping of stress fibers that were found underneath the membrane, which resulted in the defective actin cytoskeleton organization. Consequently, the expression of EGFR, a binding protein to F-actin, was also found to be suppressed. This outcome strongly supports the effects of Mel-AF in the inhibition of progressive malignant activity through the disruption of actin cytoskeleton-EGFR interaction and the EGFR signaling system. Thus, the findings of our current study indicate the potential usefulness of Mel-AF in cancer treatments as an apoptosis inducer and a potential actin-targeting agent.
APA, Harvard, Vancouver, ISO, and other styles
8

Jarernsook, B., S. Siritho, and N. Prayoonwiwat. "Efficacy and safety of beta-interferon in Thai patients with demyelinating diseases." Multiple Sclerosis Journal 19, no. 5 (September 11, 2012): 585–92. http://dx.doi.org/10.1177/1352458512459290.

Full text
Abstract:
Background: The efficacy of beta-interferon (IFN-β) treatment in Thai patients with demyelinating diseases has not been reported. Objectives: To evaluate the efficacy and any adverse drug reactions of IFN-β therapy in Thai patients, for each group of demyelinating diseases. Methods: We retrospectively reviewed data of Thai patients with multiple sclerosis (MS), neuromyelitis optica (NMO) and NMO spectrum disorders (NMOSDs) who attended the MS Clinic at Siriraj Hospital, Thailand from March 2000 to October 2011. We reviewed those 73 patients who received IFN-β. We evaluated the drug’s efficacy over 2 years and any adverse drug reactions among these patients. Results: Of the 40 MS patients who received IFN-β, 26 adhered to the medication for at least 2 years. In addition, 27 NMO/NMOSDs patients who had been diagnosed with MS were treated as such with IFN-β. In the true MS group, the pre- and post-treatment annualized relapse rates (ARR) were 1.25 and 0.59, respectively, so there was a reduction of 52.8% ( p = 0.004). In addition, in 69.2% of the patients, IFN-β also showed beneficial effects by prolonging the time to first relapse to 15.9 months and stabilizing or decreasing progression of the disease. In contrast, no significant benefit was seen in the NMO/NMOSDs group. On the contrary, an increase in EDSS was seen in 53.3 % of them. The most common side effects seen were local skin reactions and flu-like symptoms. Conclusions: Treatment with IFN-β was effective in reducing both ARR and disability progression in Thai patients with MS. In contrast, we observed that giving IFN-β treatment to NMO/NMOSDs patients may lead to a worsening of symptoms.
APA, Harvard, Vancouver, ISO, and other styles
9

Chaudhari, Latesh Y., Saurabh P. Chaudhari, and Ghanshyam M. Chavan. "A BRIEF REVIEW ON TULSI: A HOLY PLANT WITH HIGH MEDICINAL VALUES AND THERAPEUTIC USES." International Journal of Research in Ayurveda and Pharmacy 13, no. 3 (June 7, 2022): 118–25. http://dx.doi.org/10.7897/2277-4343.130372.

Full text
Abstract:
This is a medicinal plant belonging to the family Lamiaceae, and the botanical name is Ocimum Sanctum. Tulsi is widely used for its various healing properties and is called a ‘queen of the herb’. All the parts of the plant are helpful, including leaves and seeds. The Incomparable One and the mother of natural medicine are the other names of Tulsi. Tulsi is available in India, Burma, Sri Lanka, Bangladesh, Southwest Asia, China, Thailand, and Malaysia. The plant is an erect, much-branched subshrub, 30-60cm tall, with hairy stems and simple, green leaves that are strongly scented. It is native globally tropics and widely cultivated for its medicinal value. In the traditional system of medicine, different parts of Tulsi have been recommended for the treatment of bronchitis, malaria, diarrhoea, dysentery, skin diseases, eye diseases, arthritis, insect bites, and so on. Pharmacological actions like anti-cancer, antidiabetic, antioxidant, antimalarial, antimicrobial, and anti-fertility are present in the Aromatic plant. These activities may be attributed mainly to phytochemicals like eugenol, ursolic acid, rosmarinic acid, methyl chavicol, linalool, etc.
APA, Harvard, Vancouver, ISO, and other styles
10

Hackel, Meredith, Gregory Stone, and Daniel F. Sahm. "1245. In Vitro Activities of Ceftaroline and Comparator Agents Against Bacterial Pathogens Collected from Patients with Skin and Skin Structure Infections: ATLAS Global Surveillance Program 2012-2019." Open Forum Infectious Diseases 8, Supplement_1 (November 1, 2021): S711. http://dx.doi.org/10.1093/ofid/ofab466.1437.

Full text
Abstract:
Abstract Background Ceftaroline fosamil, the prodrug of ceftaroline, is a parenteral cephem approved for the treatment of patients with skin and skin structure infections (SSSIs) caused by Staphylococcus aureus (both methicillin-susceptible [MSSA] and methicillin-resistant [MRSA] isolates), β-hemolytic streptococci (Streptococcus pyogenes, S. agalactiae, S. dysgalactiae), and select species of Enterobacterales (Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca). The current study is part of the ATLAS (Antimicrobial Testing Leadership and Surveillance) program and evaluated the current activities of ceftaroline and comparator agents against commonly encountered bacterial isolates associated with SSSIs. Methods From 2012 to 2019 the ATLAS program received 124,694 bacterial isolates that had been cultured by 493 clinical laboratories in 71 countries from samples of patients diagnosed with SSSIs. All isolates were transported to IHMA, (Schaumburg, IL, USA) where their identities were confirmed using MALDI-TOF mass spectrometry and antimicrobial susceptibility testing performed following standardized CLSI broth microdilution methodology (M07). Percent susceptibilities were determined using 2021 CLSI MIC breakpoints. Phenotypic extended-spectrum β-lactamase (ESBL) screening and confirmatory testing were performed using the CLSI M100 method. Results The in vitro activity of ceftaroline is summarized in the following table. Overall, &gt;99.9% of MSSA and 92.8% of MRSA from SSSI were susceptible to ceftaroline (MIC ≤1 µg/ml); 7.1% of MRSA isolates were ceftaroline-susceptible dose-dependent (MIC 2-4 µg/ml) with greatest proportion being from Chile (53.3% of 392 isolates), S. Korea (29.3% of 321 isolates), and China (24.7% of 652 isolates). Twelve ceftaroline-resistant MRSA were observed, consisting of 11 of 109 isolates from Thailand (10.1%) and 1 of 161 from China (0.6%). All S. pyogenes and 88.0% of ESBL-negative Enterobacterales were susceptible to ceftaroline. Results Table Conclusion Ceftaroline continues to demonstrate potent in vitro activity against clinically relevant pathogens associated with SSSIs. Disclosures Meredith Hackel, PhD MPH, IHMA (Employee)Pfizer, Inc. (Independent Contractor) Gregory Stone, PhD, AztraZeneca (Shareholder, Former Employee)Pfizer, Inc. (Employee) Daniel F. Sahm, PhD, IHMA (Employee)Pfizer, Inc. (Independent Contractor)
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Skin Diseases Treatment Thailand"

1

Eke, Gozde. "Biopolymer Based Micro/nanoparticles As Drug Carriers For The Treatment Of Skin Diseases." Master's thesis, METU, 2011. http://etd.lib.metu.edu.tr/upload/12613878/index.pdf.

Full text
Abstract:
Controlled drug delivery systems are becoming increasingly interesting with the contribution of nanotechnology. In the case of transdermal applications the greatest limitation is the highly impermeable outermost layer of the skin, the stratum corneum. One promising method of controlled transdermal drug delivery of the skin therapeutics is the use of nanoparticles as carriers. Encapsulation of the drug, as opposed to classical topical application of creams or emulsions, allows the drug to diffuse into hair follicles where drug release can occur in the deeper layers of the skin. The aim of this study was to develop micro and nano sized carriers as drug delivery systems to achieve treatment for skin conditions like psoriasis, aging or UV damage, caused by radiation or health problems. Two different types of bioactive agents, retinyl palmitate (RP) and Dead Sea Water (DSW), were used by encapsulating in poly(3-hydroxybutyrate-co-3-hydroxyvalerate) carriers. In some tests MgCl2 was used as a substitute for DSW when quantification was needed. Bioactive agent loaded nanospheres and nanocapsules were prepared with o/w and w/o/w methods in low micron (1.9 µ
m), mid nano (426 nm) and nano (166 nm) sizes. Loading, encapsulation efficiency and release kinetics were studied. The encapsulation efficiency and loading values are low especially for the water soluble agents, DSW and MgCl2. It was observed that the capsules loaded with hydrophilic agents released their content in the first 24 h in aqueous media. The encapsulation efficiency and loading values for RP were higher because of the insolubility of the agent in water. In the in vitro studies carried out with L929 mouse fibroblast cells, the nano sized PHBV capsules were detected in the cytoplasm of the cells. Cell viability assay (MTT) for L929 cells showed a growth trend indicating that the particles were not cytotoxic and the values were close to the controls. Hemolytic activity was examined using human erythrocytes and micro/nanoparticles of PHBV were found to be non hemolytic. In vivo testing with BALB/c mice, nanocapsule penetration revealed that a small amount of nano sized particles penetrated the mice skin, despite the highly impermeable outer skin layer. As a result, PHBV micro/nanoparticles have a significant potential for use as topical drug delivery systems in the treatment of skin diseases.
APA, Harvard, Vancouver, ISO, and other styles
2

Zhang, Ziwei [Verfasser]. "Development of Novel Semisolids for the Treatment of Chronic Skin Diseases / Ziwei Zhang." Tübingen : Universitätsbibliothek Tübingen, 2018. http://d-nb.info/1227973497/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Summers, Jennifer F. "The effectiveness of antimicrobials for the treatment of canine pyoderma in the UK." Thesis, Royal Veterinary College (University of London), 2014. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.618326.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Abreu, Marcelle Silva de. "Pioglitazone dosage forms for the treatment of inflammation associated with skin, ocular and neurodegenerative diseases." Doctoral thesis, Universitat de Barcelona, 2018. http://hdl.handle.net/10803/650877.

Full text
Abstract:
La pioglitazona (PGZ) es un agonista del peroxisoma proliferador activado del receptor gamma (PPARγ) receptor, pertenece a la clase de las tiazolidindionas y es usado para el tratamiento de la diabetes tipo 2. Muchos estudios han reportado el uso de este fármaco con diferentes funciones, tales como: antiinflamatoria, antiangiogénica, antifibrótica, antitumoral y neuroprotectora. Además, este fármaco ha sido investigado debido a su capacidad de reducir la respuesta inflamatoria por diferentes mecanismos. Con el fin de obtener formulaciones apropiadas de PGZ que mejoren su liberación, esta tesis tuvo como principal objetivo el desarrollo y la caracterización de formas de dosificación de PGZ (nanopartículas (NPs) poliméricas de PLGA-PEG y formulaciones líquidas) capaces de reducir la inflamación asociada con enfermedades dérmicas (rosácea), oculares (uveítis) y neurodegenerativas (Alzheimer). Estos sistemas fueron optimizados y caracterizados fisicoquímicamente, analizando las interacciones fármaco-vehículo por métodos espectroscópicos y térmicos. Estudios de estabilidades fueron llevados a cabo durante 3 meses. Se estudió también la liberación in vitro, la permeación ex vivo en diferentes membranas biológicas, la tolerancia y la distribución del fármaco en los diferentes tejidos. Asimismo, estudios de toxicidad se realizaron en líneas celulares de queratinocitos (HaCat), retinoblastoma (Y-79) y células endoteliales del cerebro (hCMEC/D3). Estudios de internalización, transporte y permeabilidad de las NPs-PGZ fueron llevados a cabo en hCMEC/D3. Para finalizar se evaluó también la eficacia terapéutica in vivo de las formulaciones desarrolladas para rosácea, uveítis y Alzheimer. Las NPs-PGZ mostraron un tamaño promedio de partícula menor a 200 nm, una polidispersión aproximada de 0.1, carga superficial de -13.6 mV y una eficiencia de asociación en torno al 92 %. Los estudios de interacción fármaco-vehículo confirmaron que la PGZ fue encapsulada en la matriz polimérica. Las formas farmacéuticas fueron estables 3 meses, con un perfil reológico newtoniano. Los estudios de liberación de las formulaciones mostraron perfiles cinéticos de primer orden e hiperbólico. En los ensayos de permeación en la piel, la solución de PGZ con un promotor fue capaz de penetrar en la piel con altos valores para flujo (Jss), cantidad retenida del fármaco (Qret) y concentraciones predichas en estado de equilibrio estacionario (Css). Además, en los estudios de permeación en las distintas mucosas (bucal, sublingual, nasal e intestinal), dependiendo de la forma farmacéutica y en base a los resultados de Css, ha sido posible predecir que pueden proporcionar un efecto farmacológico sistémico tanto a nivel de la mucosa nasal como de la intestinal. Por otro lado, en el ojo la PGZ a partir de las NPs mostró altas concentraciones permeadas a través de la esclera. Los ensayos de tolerancia in vivo (Draize test) indicaron que la solución de PGZ no producía daño en la piel. Además, las NPs-PGZ no indujeron ninguna irritación a nivel ocular tanto in vivo como in vitro por el (HET CAM test). También las fórmulas fueron testadas mostrando no toxicidad a las concentraciones determinadas en las diferentes líneas celulares. Las NPs fueron capaces de internalizar, atravesar y no alterar la permeabilidad en un modelo in vitro de la barrera hematoencefálica con las células hCMEC/D3. Con respecto a la eficacia terapéutica de las formulaciones: la solución de PGZ disminuyó notablemente los niveles de eritema después de la inducción de la inflamación en las espaldas de los ratones BALB/c en todos los intervalos de tiempos analizados, corroborado por estudios histológicos. En los estudios de eficacia ocular en cerdos, las NPs-PGZ fueron capaces de prevenir la inflamación ocular después de la inducción de la inflamación con araquidonato sódico. Las NPs-PGZ también fueron testadas (in vivo) en un modelo de ratón transgénico con la enfermedad del Alzheimer y los resultados mostraron que las NPs fueron capaces de reducir el déficit de memoria cuando se comparan con el vehículo. Además, mostró clara tendencia a reducir las placas de la proteína beta amiloide. En resumen, las formulaciones de PGZ desarrolladas podrían constituir en un futuro, después de ensayos clínicos, una nueva indicación terapéutica para este fármaco.
APA, Harvard, Vancouver, ISO, and other styles
5

Giulbudagian, Michael [Verfasser]. "Development and Adaptation of Thermoresponsive Nanogels for the Treatment of Inflammatory Skin Diseases / Michael Giulbudagian." Berlin : Freie Universität Berlin, 2018. http://d-nb.info/1150238054/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Chiu, Chun-hung, and 趙俊雄. "The role of dynamic cooling in improving clinical efficacy during pulsed dye laser treatment of port wine stain in Chinese." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2003. http://hub.hku.hk/bib/B26661482.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Lee, Chuanfang. "An examination of British Chinese health care practice and beliefs : investigating the theory of planned behaviour, health-related quality of life, and Chinese medicine treatment for psoriasis." Thesis, University of Bath, 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.343766.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Ita, Kevin Bassey. "Skin delivery of selected hydrophilic drugs used in the treatment of skin diseases associated with HIV/AIDS by using elastic liposomes / Kevin Bassey Ita." Thesis, North-West University, 2003. http://hdl.handle.net/10394/302.

Full text
Abstract:
Due to the immuncompromised status of AIDS patients, secondary infections and malignancies are common. Conditions secondary to AIDS for which patients require treatment include Karposi's sarcoma (treated with methotrexate), varicella-zoster (treated with antivirals such as acyclovir) and herpes simplex (also treated with antivirals like acyclovir or idoxuridme). However the clinical efficacy of these drugs is limited by poor skin permeability. Few reports, however, have dealt with the delivery of low molecular weight hydrophilic drugs from these vesicles (El Maghraby et al, 2000). The aim of our study was to investigate in vitro permeation of methotrexate, acyclovir and idoxuridine across human epidermal membrane from elastic liposomes. The intent was to establish whether formulation of these hydrophilic drugs into elastic liposomes would enhance their skin permeation parameters. We developed and validated high-performance liquid chromatographic techniques for quantitative analysis of methotrexate, idoxuridine and acyclovir. Elastic liposomes were prepared from various phospholipids- phosphatidylcholine 78.6%; phosphatidylcholine 50%; hydrogenated phosphatidylcholine 90%; phosphatidylcholine 95% and surfactants - sodium cholate, sodium deoxycholate, Span 20, 40, 60, 80. These vesicles were characterised by transmission electron microscopy. The solubilities of methotrexate, acyclovir and idoxuridine were determined. Phospholipon G (95% phosphatidylcholine) was chosen for the preparation of the liposomes with different surfactants. Permeation of methotrexate, acyclovir and idoxuridme from these vesicles across human epidermal membrane was investigated. Flux values for methotrexate, acyclovir and idoxuridine values (J) obtained by curve-fitting of data using Easyplot were compared to those obtained by linear regression. We used Student's t-test to determine statistically significant differences in the flux values of the formulations. A computer program http://www.physics.csbsju.edu/stats/ttest- bulk-form.html was used for this purpose. Our results indicate that there are no statistically significant differences between flux values from elastic liposomes and saturated aqueous solutions.
Thesis (Ph.D. (Pharmaceutics))--North-West University, Potchefstroom Campus, 2004.
APA, Harvard, Vancouver, ISO, and other styles
9

Mahachi, Josia. "Medicinal properties of some plants used for the treatment of skin disorders in the O. R. Tambo and Amathole Municipalities of the Eastern Cape Province, South Africa." Thesis, Walter Sisulu University, 2013. http://hdl.handle.net/11260/101.

Full text
Abstract:
The use of medicinal plants for treatment of skin infections and improvement of skin tone was assessed. The study covered Amathole and OR Tambo municipalities of the Eastern Cape Province of South Africa. The study sought to identify and document some medicinal plants which are used by the indigenous people on the skin, evaluate some biological properties which attribute to their use for therapeutic use. This report provides ethnobotanical data on some plant which were identified. Six medicinal plants (Kniphofia drepanophylla, Gnidia capitata, Hypoxis hemerocallidea, Syzgium cordatum, Macaranga capensis and Protorhus longifolia) which were implicated for treatment of skin diseases were screened for their antibacterial and antioxidant properties. Guided questionnaires were used to interview and gather ethnobotanical information from the traditional healers. Members of the communities which were indicated to be knowledgeable on use of medicinal plants in the areas were visited and interviewed. The results revealed that a total of 45 plant species distributed in 41 Genera belonging to 28 Families are used for treatment of skin infections and improvement of skin texture. The plant medicines were reported to be used as remedies against common skin problem such as wounds, pimples, acnes and itches. Some were reported to have anti-inflammatory effect on the skin while other were reported to oil dry skin and prevent skin dryness and dry eczematous conditions. Others like Cassipourea flanaganii, and Spirostachys africana were commonly used to enlighten skin and protect skin from ultra-violet radiation. The most common mode of preparation of these medicinal plants was pastes or decoctions. Sometimes crushed plant materials were put in bathing water or boiled and steamed on affected parts. It was reported that mixing pastes with oil, animal fat and milk improve medicinal properties. Water, methanol and acetone extracts of K. drepanophylla, G. capitata, H. hemerocallidea, S. cordatum, M. capensis and P. longifolia were screened against five strains of Gram negative bacteria. The results revealed that water extracts from five plant species inhibited two or more strains of bacteria with the most common minimum inhibitory concentrations (MICs) ranging between 5,0 to 10,0 mg/ml with the exception of aqueous extracts of K. drepanophylla which failed to inhibit all strains of bacteria. The screening of methanol extract of these plants for antioxidant and free radical activity revealed a significant activity with 1, 1-diphenyl-2-picryl-hydrazyl (DPPH) free radical (DPPH). The extracts of P. longifolia, G. capitata, M. capensis, S. cordutum and H. hemerocallidea showed significantly higher free radical scavenging activity with IC50 of ranging from about 11.0 to 41.2 μg/ ml while the IC50 value for K. drepanophylla could not be determined at 100 μg/ ml. Generally the study showed that medicinal plants still play a very important role in the health care delivery system, especially in the O R Tambo and Amathole municipalities of the Eastern Cape. Botanical medicine remains pivotal in the treatment of skin ailments and improvement of the skin tone.
APA, Harvard, Vancouver, ISO, and other styles
10

何慧潔. "嬰兒濕瘡的中醫治療和臨床研究現狀." HKBU Institutional Repository, 2009. http://repository.hkbu.edu.hk/etd_ra/1024.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Skin Diseases Treatment Thailand"

1

Zaidi, Zohra, Khalid Hussain, and Simi Sudhakaran. Treatment of Skin Diseases. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-89581-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Julian, Verbov, ed. Treatment in dermatology. Lancaster, England: MTP Press, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

J, Margesson Lynette, ed. Genital skin disorders: Diagnosis and treatment. St. Louis: Mosby, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Alderson, W. E. Treatment of skin diseases: Viral conditions. Bradford: University of Bradford School of Studies in Pharmacology, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

1886-, Roxburgh A. C., and Kirby John D, eds. Roxburgh's common skin diseases. London: Chapman & Hall Medical, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Marwali, Harahap, ed. Diagnosis and treatment of skin infections. Oxford: Blackwell Science, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Skin disorders: Diagnosis and treatment. New York: Igaku-Shoin, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Modern management of common skin diseases. Edinburgh: Churchill Livingstone, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Bork, K. Diagnosis and treatment of common skin diseases. Philadelphia: W.B. Saunders, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Leppard, Barbara. Treatment in dermatology. Oxford: Radcliffe Medical, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Skin Diseases Treatment Thailand"

1

Zaidi, Zohra, Khalid Hussain, and Simi Sudhakaran. "Sexually Transmitted Diseases." In Treatment of Skin Diseases, 367–79. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-89581-9_26.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Agarwal, Madhuri. "Treatment of Cellulite." In Skin Diseases in Females, 535–47. Singapore: Springer Nature Singapore, 2022. http://dx.doi.org/10.1007/978-981-16-6065-8_25.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Zaidi, Zohra, Khalid Hussain, and Simi Sudhakaran. "Diagnosis of Skin Disease." In Treatment of Skin Diseases, 3–7. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-89581-9_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Zaidi, Zohra, Khalid Hussain, and Simi Sudhakaran. "Tumours of the Skin." In Treatment of Skin Diseases, 273–99. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-89581-9_20.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Zaidi, Zohra, Khalid Hussain, and Simi Sudhakaran. "Sports Related Skin Injuries." In Treatment of Skin Diseases, 399–405. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-89581-9_30.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Zaidi, Zohra, Khalid Hussain, and Simi Sudhakaran. "Management of Dry Skin." In Treatment of Skin Diseases, 495–98. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-89581-9_39.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Assaf, Chalid, and Wolfram Sterry. "Treatment of Cutaneous Lymphomas." In Therapy of Skin Diseases, 633–41. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-540-78814-0_55.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Zaidi, Zohra, Khalid Hussain, and Simi Sudhakaran. "Diorders of Pigmentation." In Treatment of Skin Diseases, 159–70. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-89581-9_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Zaidi, Zohra, Khalid Hussain, and Simi Sudhakaran. "Diseases Due to Ultraviolet Radiation." In Treatment of Skin Diseases, 171–84. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-89581-9_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Zaidi, Zohra, Khalid Hussain, and Simi Sudhakaran. "Cutaneous Reactions Due to Cold." In Treatment of Skin Diseases, 185–90. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-89581-9_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Skin Diseases Treatment Thailand"

1

Welzel, Julia, Maike Bruhns, Christina Schröder, and Reginald Birngruber. "Clinical OCT Studies in Dermatology: Inflammatory Skin Diseases and Treatment Effects." In Biomedical Topical Meeting. Washington, D.C.: OSA, 1999. http://dx.doi.org/10.1364/bio.1999.awb7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Pottier, Roy. "Treatment of skin diseases by using red light and a natural photosensitizer." In Opto-Canada: SPIE Regional Meeting on Optoelectronics, Photonics, and Imaging, edited by John C. Armitage. SPIE, 2017. http://dx.doi.org/10.1117/12.2283894.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Liu, Chun-Li, Wai-Hua Yuan, Wei-Wei Yuan, and Qiang Fu. "Clinical application of versapulse laser in the treatment of skin pigmentation diseases." In 1997 Shanghai International Conference on Laser Medicine and Surgery, edited by Jing Zhu. SPIE, 1998. http://dx.doi.org/10.1117/12.330131.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Shcherbakov, Ivan A., Igor V. Klimov, Vladimir B. Tsvetkov, Alexander I. Nerobeev, Lija B. Sadovnikova, and Vladimir I. Eliseenko. "Application of 2-um wavelength holmium lasers for treatment of skin diseases." In OE/LASE '94, edited by R. Rox Anderson. SPIE, 1994. http://dx.doi.org/10.1117/12.184905.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Nimitha, N., J. Aarthi, M. Bhuvaneshwari, L. Brindha, and P. L. Divya. "Diagnosis and treatment recommendation engine for skin diseases using AI model VGG19." In EIGHTH INTERNATIONAL CONFERENCE NEW TRENDS IN THE APPLICATIONS OF DIFFERENTIAL EQUATIONS IN SCIENCES (NTADES2021). AIP Publishing, 2022. http://dx.doi.org/10.1063/5.0072492.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Olenev, Evgeniy, Walid Al-Haidri, and Olga Lebedinskaya. "Method and Device for Treatment of Fungal Diseases of the Skin and Nails." In 2019 Ural Symposium on Biomedical Engineering, Radioelectronics and Information Technology (USBEREIT). IEEE, 2019. http://dx.doi.org/10.1109/usbereit.2019.8736581.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Lei, Xia, and Yang Tan. "Effect and mechanisms of photodynamic therapy in treating chronic skin ulcers infected with Pseudomonas aeruginosa (Conference Presentation)." In Photonic Diagnosis and Treatment of Infections and Inflammatory Diseases, edited by Tianhong Dai. SPIE, 2018. http://dx.doi.org/10.1117/12.2289032.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Fricke, Dierk, Stephan Maas, Lennart Jütte, Merve Wollweber, and Bernhard Roth. "Non-contact fast Mueller matrix measurement system for investigation of inflammatory skin diseases." In Photonic Diagnosis, Monitoring, Prevention, and Treatment of Infections and Inflammatory Diseases 2019, edited by Tianhong Dai, Mei X. Wu, and Jürgen Popp. SPIE, 2019. http://dx.doi.org/10.1117/12.2509766.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Saltan Fatma, Z. "Turkish medicinal and aromatic plants for the treatment of skin diseases both human and animals." In GA 2017 – Book of Abstracts. Georg Thieme Verlag KG, 2017. http://dx.doi.org/10.1055/s-0037-1608167.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Zivkovic, J., E. Spanidi, K. Gardikis, and M. Pisev. "Medicinal plants in the treatment of skin diseases in Serbia during 19th and 20th century." In GA – 70th Annual Meeting 2022. Georg Thieme Verlag KG, 2022. http://dx.doi.org/10.1055/s-0042-1758991.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Skin Diseases Treatment Thailand"

1

LI, jianhong, Zhuang LI, Yalin SHE, and Guohua LIN. Assessment of acupuncture for treating herpes zoster:a protocol for an umbrella systematic review and meta analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2022. http://dx.doi.org/10.37766/inplasy2022.4.0010.

Full text
Abstract:
Review question / Objective: Patients who suffer from HZ in line with the consensus of Chinese experts will be included, regardless of sex, race and time of onset . Those who diagnosed with PHN, auto-immune diseases, pregnant women will be excluded.Acupuncture, electroacupuncture, fire needle, skin acupuncture, plum blossom needle, auriculo-acupuncture all these such therapies in treating herpes zoster will be included.The control group’s treatment includes drug therapy (such as antiviral acyclovir nutritional nerve medicine or traditional Chinese medicine, etc.) ，sham acupuncture, placebo, no treatment, and so on except acupuncture therapy. efficacy rate (with reference to the guiding principles of Clinical Research of New drugs in China (trial)).pain evaluation (pain relief time, pain intensity, visual analogue score, VAS), incidence of residual neuralgia PHN.
APA, Harvard, Vancouver, ISO, and other styles
2

Noga, Edward J., Angelo Colorni, Michael G. Levy, and Ramy Avtalion. Importance of Endobiotics in Defense against Protozoan Ectoparasites of Fish. United States Department of Agriculture, September 2003. http://dx.doi.org/10.32747/2003.7586463.bard.

Full text
Abstract:
Infectious disease is one of the most serious causes of economic loss in all sectors of aquaculture. There is a critical need to understand the molecular basis for protection against infectious disease so that safer, more reliable and more cost-effective strategies can be designed for their control. As part of this effort, the major goal of our BARD project was to determine the importance of endobiotics as a defense against protozoan ectoparasites in fish. Endobiotics, or antimicrobial polypeptides, are peptides and small proteins that are increasingly recognized as having a vital role in the innate defense of virtually all animals. One objective of our BARD project was to determine the antiparasitic potency of one specific group of endobiotics that were isolated from hybrid striped bass (Morone saxatilis x M chrysops). We found that these endobiotics, which we had previously named histone-like proteins (HLPs), exhibited potent activity against Amyloodinium and that the putative levels of HLPs in the skin were well within the levels that we found to be lethal to the parasite in vitro. We also found evidence for the presence of similar antibiotics in sea bream (Sparus aurata) and Mediterranean sea bass (Dicentrarchus labrax). We also examined the effect of chronic stress on the expression of HLP in fish and found that HLP levels were dramatically decreased after only one week of a crowding/high ammonia sublethal stress. We also began to explore the feasibility of upregulating endobiotics via immunostimulation. However, we did not pursue this objective as fully as we originally intended because we spent a much larger effort than originally anticipated on the last objective, the attempted isolation of novel endobiotics from hybrid striped bass. In this regard, we purified and identified four new peptide endobiotics. These endobiotics, which we have named piscidins (from "Pisces" meaning fish), have potent, broad-spectrum activity against a number of both fish and human pathogens. This includes not only parasites but also bacteria. We also demonstrated that these peptides are present in the mast cell. This was the first time that the mast cell, the most common tissue granulocyte in vertebrates, was shown to possess any type of endobiotic. This finding has important implications in explaining the possible function of mast cells in the immune response of vertebrates. In summary, the research we have accomplished in this BARD project has demonstrated that endobiotics in fish have potent activity against many serious pathogens in aquaculture and that there is considerable potential to use these compounds as stress indicators in aquaculture. There is also considerable potential to use some of these compounds in other areas of medicine, including treatment of serious infectious diseases of humans and animals.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Skin Diseases Treatment Thailand' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography